nifedipine has been researched along with Cystic Fibrosis of Pancreas in 8 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous studies have indicated that there is weak genetic linkage between the defective gene in cystic fibrosis (CFTR) and the gene encoding the nifedipine metabolizing enzyme P4503A4 which are both located on chromosome 7." | 7.68 | Deficient nifedipine oxidation: a rare inherited trait associated with cystic fibrosis kindreds. ( Allen, J; Bilton, D; Braganza, JM; Daly, AK; Idle, JR; Knight, AD; Salh, BS; Webb, AK, 1992) |
| "The acute effects of oxygen, nifedipine, and diltiazem were studied in eight patients with cystic fibrosis and mild pulmonary hypertension, to assess the possibility of relieving the latter before the occurrence of irreversible vascular changes." | 7.67 | Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension. ( Bossuyt, A; Dab, I; Davidson, A, 1989) |
| "Nifedipine has recently been reported to reduce pulmonary artery pressure and pulmonary vascular resistance during rest and exercise in adult patients with hypoxic pulmonary hypertension from chronic obstructive pulmonary disease." | 5.27 | Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. ( Fitzpatrick, S; Kennedy, TP; Michael, JR; Rosenstein, BJ, 1984) |
| "Previous studies have indicated that there is weak genetic linkage between the defective gene in cystic fibrosis (CFTR) and the gene encoding the nifedipine metabolizing enzyme P4503A4 which are both located on chromosome 7." | 3.68 | Deficient nifedipine oxidation: a rare inherited trait associated with cystic fibrosis kindreds. ( Allen, J; Bilton, D; Braganza, JM; Daly, AK; Idle, JR; Knight, AD; Salh, BS; Webb, AK, 1992) |
| "The acute effects of oxygen, nifedipine, and diltiazem were studied in eight patients with cystic fibrosis and mild pulmonary hypertension, to assess the possibility of relieving the latter before the occurrence of irreversible vascular changes." | 3.67 | Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension. ( Bossuyt, A; Dab, I; Davidson, A, 1989) |
| "Nifedipine has recently been reported to reduce pulmonary artery pressure and pulmonary vascular resistance during rest and exercise in adult patients with hypoxic pulmonary hypertension from chronic obstructive pulmonary disease." | 1.27 | Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. ( Fitzpatrick, S; Kennedy, TP; Michael, JR; Rosenstein, BJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budriesi, R | 1 |
| Ioan, P | 1 |
| Leoni, A | 1 |
| Pedemonte, N | 1 |
| Locatelli, A | 1 |
| Micucci, M | 1 |
| Chiarini, A | 1 |
| Galietta, LJ | 1 |
| Chung, WJ | 1 |
| Goeckeler-Fried, JL | 1 |
| Havasi, V | 1 |
| Chiang, A | 1 |
| Rowe, SM | 1 |
| Plyler, ZE | 1 |
| Hong, JS | 1 |
| Mazur, M | 1 |
| Piazza, GA | 1 |
| Keeton, AB | 1 |
| White, EL | 1 |
| Rasmussen, L | 1 |
| Weissman, AM | 1 |
| Denny, RA | 1 |
| Brodsky, JL | 1 |
| Sorscher, EJ | 1 |
| Michael, JR | 1 |
| Kennedy, TP | 1 |
| Fitzpatrick, S | 1 |
| Rosenstein, BJ | 1 |
| Daly, AK | 1 |
| Salh, BS | 1 |
| Bilton, D | 1 |
| Allen, J | 1 |
| Knight, AD | 1 |
| Webb, AK | 1 |
| Braganza, JM | 1 |
| Idle, JR | 1 |
| Eichler, I | 1 |
| Burghuber, OC | 1 |
| Götz, M | 1 |
| Davidson, A | 1 |
| Bossuyt, A | 1 |
| Dab, I | 1 |
| Hussein, A | 1 |
| Koch, I | 1 |
| Schmidt-Redemann, B | 1 |
| Geggel, RL | 1 |
| Dozor, AJ | 1 |
| Fyler, DC | 1 |
| Reid, LM | 1 |
8 other studies available for nifedipine and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines.
Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Bacterial Proteins; Cell Line; Cystic Fibrosi | 2011 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regu | 2016 |
Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale.
Topics: Adult; Combined Modality Therapy; Cystic Fibrosis; Hemodynamics; Humans; Hypoxia; Lung; Male; Nifedi | 1984 |
Deficient nifedipine oxidation: a rare inherited trait associated with cystic fibrosis kindreds.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Base Sequence; Cystic Fibrosis; Cytochrome P-450 C | 1992 |
Acute effects on pulmonary haemodynamics of nifedipine in adult patients with cystic fibrosis.
Topics: Adult; Blood Pressure; Cystic Fibrosis; Hemodynamics; Humans; Hypoxia; Nifedipine; Pulmonary Alveoli | 1990 |
Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension.
Topics: Adolescent; Adult; Airway Resistance; Cystic Fibrosis; Diltiazem; Female; Hemodynamics; Humans; Hype | 1989 |
[Noninvasive methods for assessing the effect of nifedipine on cardiorespiratory function in a patient with cystic fibrosis].
Topics: Adult; Cystic Fibrosis; Humans; Hypertension, Pulmonary; Male; Nifedipine; Pulmonary Heart Disease; | 1988 |
Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
Topics: Adult; Chronic Disease; Cystic Fibrosis; Exercise Test; Female; Hemodynamics; Humans; Hydralazine; M | 1985 |